MA26730A1 - Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents
Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenantInfo
- Publication number
- MA26730A1 MA26730A1 MA25963A MA25963A MA26730A1 MA 26730 A1 MA26730 A1 MA 26730A1 MA 25963 A MA25963 A MA 25963A MA 25963 A MA25963 A MA 25963A MA 26730 A1 MA26730 A1 MA 26730A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- antagonist compounds
- npy antagonist
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000002660 neuropeptide Y receptor antagonist Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13202999P | 1999-04-30 | 1999-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26730A1 true MA26730A1 (fr) | 2004-12-20 |
Family
ID=22452122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25963A MA26730A1 (fr) | 1999-04-30 | 2000-04-26 | Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6355635B1 (fr) |
| AR (1) | AR028824A1 (fr) |
| AU (1) | AU2935200A (fr) |
| CO (1) | CO5170414A1 (fr) |
| GT (1) | GT200000057A (fr) |
| HN (1) | HN2000000041A (fr) |
| MA (1) | MA26730A1 (fr) |
| PA (1) | PA8493701A1 (fr) |
| PE (1) | PE20010118A1 (fr) |
| TN (1) | TNSN00092A1 (fr) |
| UY (1) | UY26130A1 (fr) |
| WO (1) | WO2000066578A1 (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60022386T2 (de) * | 1999-12-16 | 2006-06-22 | Schering Corp. | Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten |
| US6894063B2 (en) * | 2000-09-14 | 2005-05-17 | Schering Corporation | Substituted urea neuropeptide Y Y5 Receptor antagonists |
| US20050043256A1 (en) * | 2001-07-30 | 2005-02-24 | Isis Pharmaceuticals, Inc. | Antisense modulation of stearoyl-CoA desaturase expression |
| US20050107411A1 (en) * | 2001-12-17 | 2005-05-19 | Macneil Douglas J. | Method for treating circadian rhythm disruptions |
| PL372390A1 (en) * | 2002-02-05 | 2005-07-25 | Novo Nordisk A/S | Novel aryl- and heteroarylpiperazines |
| ATE486842T1 (de) | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
| BR0314872A (pt) * | 2002-10-18 | 2005-08-02 | Pfizer Prod Inc | Ligandos do receptor canabinóide e usos dos mesmos |
| US20060148721A1 (en) * | 2003-06-06 | 2006-07-06 | Erondu Ngozi E | Combination therapy for the treatment of dyslipidemia |
| MXPA06001053A (es) | 2003-07-29 | 2006-04-11 | Novo Nordisk As | Piridazinil-piperazinas y su uso como ligandos del receptor de histamina h3. |
| JP2007506728A (ja) * | 2003-09-26 | 2007-03-22 | ファイザー・プロダクツ・インク | 概日リズム障害を治療するためのnpyy5受容体アンタゴニストの使用 |
| MXPA06003393A (es) * | 2003-09-26 | 2006-06-08 | Pfizer Prod Inc | Tratamiento de trastornos neurologicos relacionados con alteraciones del sueno de movimientos oculares rapidos (rem) con antagonistas de receptor npy y5. |
| US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| DE102004003812A1 (de) * | 2004-01-25 | 2005-08-11 | Aventis Pharma Deutschland Gmbh | Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US20050256124A1 (en) * | 2004-04-15 | 2005-11-17 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| US20060039890A1 (en) * | 2004-08-20 | 2006-02-23 | Renshaw Perry F | Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant |
| EP1804799B1 (fr) | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Dérivés hétérocycliques et leur utilisation en tant qu'agents thérapeutiques |
| EP2316458A1 (fr) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Derives de pyridazine destines a l'inhibition du desaturase-coa-stearoyl de l'humain |
| EP1799667B1 (fr) | 2004-09-20 | 2013-03-20 | Xenon Pharmaceuticals Inc. | Derives heterocycliques et leur utilisation comme agents therapeutiques |
| US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| EP2289510A1 (fr) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Dérivés hétérocycliques pour le traitement des maladies induites par des enzymes stearoyl-coa desaturase |
| US7767677B2 (en) | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| CA2580856A1 (fr) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Derives heterocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase |
| US20080064632A1 (en) * | 2004-09-24 | 2008-03-13 | Amatruda John M | Combination Therapy for the Treatment of Obesity |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| EP2029138A1 (fr) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine |
| CN103110635A (zh) | 2005-07-04 | 2013-05-22 | 海波因特制药有限责任公司 | 组胺h3受体拮抗剂 |
| CA2634442A1 (fr) * | 2005-12-22 | 2007-07-05 | Icagen, Inc. | Antagonistes du canal calcique |
| CA2653062A1 (fr) | 2006-05-23 | 2007-11-29 | Transtech Pharma, Inc. | Nouveaux medicaments |
| ATE538116T1 (de) | 2006-05-29 | 2012-01-15 | High Point Pharmaceuticals Llc | 3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist |
| US8849577B2 (en) * | 2006-09-15 | 2014-09-30 | Metabolon, Inc. | Methods of identifying biochemical pathways |
| DK2125797T3 (da) * | 2007-03-16 | 2014-02-10 | Actelion Pharmaceuticals Ltd | Aminopyridinderivater som s1p1/edg1-receptoragonister |
| EP2014656A3 (fr) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Nouveaux antagonistes d'hétéocycliques h3 |
| EP2280703A1 (fr) * | 2008-03-12 | 2011-02-09 | Københavns Universitet (University Of Copenhagen) | Utilisation d antagonistes de récepteur npy y5 pour la prévention de l abus de psychostimulants et d opioïdes |
| WO2010065668A1 (fr) * | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibiteurs du virus de l'hépatite c de type ns5a |
| JP5629380B2 (ja) | 2010-12-17 | 2014-11-19 | 田辺三菱製薬株式会社 | 連続芳香環式化合物 |
| ES2690315T3 (es) | 2012-06-15 | 2018-11-20 | Mitsubishi Tanabe Pharma Corporation | Compuestos de imidazol y triazol como inhibidores de DGAT-1 |
| WO2016105491A1 (fr) * | 2014-12-23 | 2016-06-30 | Fgh Biotech | Compositions de composés hétérocycliques à base de fatostatine et utilisations associées |
| KR20220104000A (ko) * | 2019-11-19 | 2022-07-25 | 모다크 게엠베하 | 알파-시누클레인의 응집과 관련된 질병의 진단, 치료 및 예방을 위한 신규한 화합물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440774A (en) | 1975-03-03 | 1984-04-03 | Merck & Co., Inc. | 3-Amino-2-hydroxypropoxyaryl imidazole derivatives |
| US4853383A (en) | 1975-03-03 | 1989-08-01 | Merck & Co., Inc. | β-blocking substituted imidazoles |
| JPH0251150A (ja) * | 1988-08-12 | 1990-02-21 | Konica Corp | 新規なシアンカプラーを含有するハロゲン化銀写真感光材料 |
| DE3935514A1 (de) | 1989-10-25 | 1991-05-02 | Boehringer Mannheim Gmbh | Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP0448765B1 (fr) * | 1990-03-30 | 1994-08-17 | HEUMANN PHARMA GMBH & CO | Uitlisation de dérivés de la guanidine pour la fabrication d'un médicament à activité antagoniste du neuropeptide Y |
| US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| WO1996014307A1 (fr) | 1994-11-07 | 1996-05-17 | Pfizer Inc. | Certains derives de benzylamine a substitutions; une nouvelle classe de ligands specifiques du neuropeptide y1 |
| EP0759441A3 (fr) * | 1995-06-30 | 1999-06-30 | Eli Lilly And Company | Procédés de traitement des pathologies associées aux peptides neuropeptide Y |
| US6121260A (en) * | 1997-07-03 | 2000-09-19 | Neurogen Corporation | Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives |
| US6054590A (en) * | 1998-03-25 | 2000-04-25 | Bristol-Myers Squibb Company | Imidazolone anorectic agents: II. phenyl derivatives |
-
2000
- 2000-03-16 AU AU29352/00A patent/AU2935200A/en not_active Abandoned
- 2000-03-16 WO PCT/IB2000/000291 patent/WO2000066578A1/fr not_active Ceased
- 2000-03-31 US US09/540,127 patent/US6355635B1/en not_active Expired - Fee Related
- 2000-03-31 HN HN2000000041A patent/HN2000000041A/es unknown
- 2000-04-04 CO CO00024431A patent/CO5170414A1/es not_active Application Discontinuation
- 2000-04-12 PA PA84937A patent/PA8493701A1/es unknown
- 2000-04-26 MA MA25963A patent/MA26730A1/fr unknown
- 2000-04-26 TN TNTNSN00092A patent/TNSN00092A1/fr unknown
- 2000-04-27 UY UY26130A patent/UY26130A1/es not_active Application Discontinuation
- 2000-04-27 AR ARP000102008A patent/AR028824A1/es unknown
- 2000-04-28 GT GT200000057A patent/GT200000057A/es unknown
- 2000-04-28 PE PE2000000401A patent/PE20010118A1/es not_active Application Discontinuation
-
2001
- 2001-01-04 US US09/754,770 patent/US6514966B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PA8493701A1 (es) | 2002-07-30 |
| US6355635B1 (en) | 2002-03-12 |
| PE20010118A1 (es) | 2001-02-03 |
| TNSN00092A1 (fr) | 2005-11-10 |
| AR028824A1 (es) | 2003-05-28 |
| AU2935200A (en) | 2000-11-17 |
| WO2000066578A1 (fr) | 2000-11-09 |
| HN2000000041A (es) | 2001-02-02 |
| UY26130A1 (es) | 2000-12-29 |
| CO5170414A1 (es) | 2002-06-27 |
| US6514966B2 (en) | 2003-02-04 |
| US20010039277A1 (en) | 2001-11-08 |
| GT200000057A (es) | 2001-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26712A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2780057B1 (fr) | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26622A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26740A1 (fr) | Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26630A1 (fr) | 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26743A1 (fr) | Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2729951B1 (fr) | Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant | |
| MA26687A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26680A1 (fr) | Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26686A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2827604B1 (fr) | Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant | |
| MA26611A1 (fr) | Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26669A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2794742B1 (fr) | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant | |
| DZ3000A1 (fr) | Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant. | |
| MA26624A1 (fr) | Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26707A1 (fr) | Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| FR2805536B1 (fr) | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant | |
| MA26501A1 (fr) | Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26642A1 (fr) | Derives de sulfonylbenzene nouveaux, procédé pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA26619A1 (fr) | Composes azabicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26597A1 (fr) | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26631A1 (fr) | Composes a fonction bis-aminomethyl-carbonyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26594A1 (fr) | Composes nouveaux inhibiteurs de mmp, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26583A1 (fr) | Derives de benzamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |